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Rare diseases are a threat to the health of EU citizens, in
so far as they are life-threatening or chronically debili-
tating diseases with a low prevalence and a high level of
complexity. Despite their rarity, there are so many dif-
ferent types of rare diseases that millions of people are
affected. The focus on rare diseases and the recognition
of the fact that rare diseases have common issues in a
public health perspective and require specifically tar-
geted policies, is a relatively new achievement in most
EU member states. There is at present great variability
among countries about the type of services provided to
rare disease patients and the accessibility to these ser-
vices. Following the Council Recommendations, each
Member State should (preferably by the end of 2013)
establish and implement plans or strategies for rare dis-
eases at the appropriate level. The aim is to ensure that
all patients with a rare disease in Europe have equal
access to high-quality care, including diagnostics, treat-
ments and rehabilitation. The European Project for Rare
Diseases National Plans Development (EUROPLAN),
has the task of elaborating documents to facilitate the
establishment and implementation of National Plans or
Strategies. EUROPLAN has defined a National Plan or
Strategy as a set of integrated and comprehensive health
and social policy actions for rare diseases, to be devel-
oped and implemented at national level, and charac-
terised by identified objectives to be achieved within a
specified timeframe. The EUROPLAN guidance docu-
ment (recommendations) provides a set of “tools and
examples” on how activities for rare diseases can be
organised at national (and European) level on different
areas, e.g. the coding (and traceability) of rare diseases,
research, centres of expertise and the empowerment of
patient organisations for rare diseases.
(http://www.europlanproject.eu)
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